EODData

LSE, 0Q77: AB Science SA

03 Apr 2026
LAST:

1.216

CHANGE:
 0.00
OPEN:
1.216
HIGH:
1.216
ASK:
0.000
VOLUME:
12
CHG(%):
0.00
PREV:
1.216
LOW:
1.216
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Apr 261.2161.2161.2161.21612
02 Apr 261.2161.2161.2161.216100
01 Apr 261.2041.2061.2041.2061.2K
31 Mar 261.2041.2061.2041.2061.2K
30 Mar 261.1501.1501.1501.150100
27 Mar 261.1881.1881.1881.1882
26 Mar 261.1501.1801.1501.17419.4K
25 Mar 261.1501.1801.1501.174100
24 Mar 261.2261.2261.1801.1804.0K
23 Mar 261.2001.2201.1841.220100

PROFILE

Name:AB Science SA
About:AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France. The company's lead drug candidate is masitinib, a selective protein kinase inhibitor that targets mast cells and microglia in Phase 3 trial for the treatment of amyotrophic lateral sclerosis, progressive forms of multiple sclerosis, Alzheimer's disease, and indolent systemic mastocytosis, as well as in Phase 2 trial for mast cell activation syndrome and sickle cell disease. It also develops AB8939, a microtubule destabilizer in Phase 1 trial for the treatment of acute myeloid leukemia; and AB12319 in preclinical trial to treat sarcoma and solid tumors. In addition, the company markets its masitinib under the Masivet brand for the treatment of mast cell tumors in dogs in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
Address:3, Avenue George V, Paris, France, 75008
Website:https://www.ab-science.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-128.40 
Price to Sales:50.69 
Price to Book:-3.43 
Operating Margin:-5.30 
Return on Assets:-0.15 
Return on Equity:-0.07 
EPS Ratio:-0.30 
Revenue:1.03M 
Shares:41.06M 
Market Cap:49.93M 

TECHNICAL INDICATORS

MA5:1.201.4%
MA10:1.191.9%
MA20:1.220.6%
MA50:1.306.9%
MA100:1.306.6%
MA200:1.306.7%
STO9:86.84 
STO14:70.21
RSI14:42.55
WPR14:-29.79
MTM14:-0.03
ROC14:-0.02 
ATR:0.02 
Week High:1.220.0%
Week Low:1.155.7%
Month High:1.317.7%
Month Low:1.156.7%
Year High:1.7241.3%
Year Low:0.9725.4%
Volatility:22.33